The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function A systematic review and network meta-analysis

Medicine (United States)

Volumn 95, Issue 24, 2016, Pages

  Li, Zhuo ^a   Chen, Ping ^a   Wang, Jun ^b   Mao, Qi ^a   Xiang, Han ^a   Wang, Xiao ^c   Wang, Xinghuan ^a   Zhang, Xinhua ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Wuhan Children's Hospital   (China)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; ERECTILE DYSFUNCTION; HOLMIUM LASER ENUCLEATION OF THE PROSTATE; HOLMIUM LASER RESECTION OF THE PROSTATE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LAPAROSCOPIC SIMPLE PROSTATECTOMY; LAPAROSCOPIC SURGERY; LOWER URINARY TRACT SYMPTOM; MALE; MALE ERECTILE FUNCTION; MALE GENITAL SYSTEM FUNCTION; META ANALYSIS; PHOTOSELECTIVE VAPORIZATION OF THE PROSTATE; PLASMAKINETIC ENUCLEATION OF THE PROSTATE; PLASMAKINETIC RESECTION OF THE PROSTATE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SURGERY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL APPROACH; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; COMPLICATION; LOWER URINARY TRACT SYMPTOMS; PATHOPHYSIOLOGY; PENIS ERECTION; PHYSIOLOGY; PROSTATIC HYPERPLASIA; QUALITY OF LIFE;

ERECTILE DYSFUNCTION; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; PENILE ERECTION; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 84976347313     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003862     Document Type: Review

References (69)

1. Gratzke C, Bachmann A, Descazeaud A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2015;67:1099-109.
2. Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 2015;22(5 suppl 1):1-6.
3. Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338:469-71.
4. Chute CG, Panser LA, Girman CJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993;150:85-9.
5. Sexton CC, Coyne KS, Kopp ZS, et al. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTS. Br J Urol Int 2009;103(suppl 3): 12-23.
6. Barry MJ, Cantor A, Roehrborn CG, et al. Relationships among participant international prostate symptom score, benign prostatic hyperplasia impact index changes and global ratings of change in a trial of phytotherapy in men with lower urinary tract symptoms. J Urol 2013;189:987-92.
7. Kupelian V, McVary KT, Kaplan SA, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J Urol 2009;182:616-24.
8. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003;44:637-49.
9. McVary KT. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 2005;47:838-45.
10. Kohler TS, McVary KT. The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors. Eur Urol 2009;55:38-48.
11. Ozayar A, Zumrutbas AE, Yaman O. The relationship between lower urinary tract symptoms (LUTS), diagnostic indicators of benign prostatic hyperplasia (BPH), and erectile dysfunction in patients with moderate to severely symptomatic BPH. Int Urol Nephrol 2008;40:933-9.
12. Miner M, Rosenberg MT, Perelman MA. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function. Clin Therapeut 2006;28:13-25.
13. Roehrborn CG. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin N Am 2011;95:87-100.
14. Oelke M, Bachmann A, Descazeaud A, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2013;64: 118-40.
15. Jung JH, Jae SU, Kam SC, et al. Correlation between Lower Urinary Tract Symptoms (LUTS) and sexual function in benign prostatic hyperplasia: impact of treatment of LUTS on sexual function. J Sex Med 2009;6:2299-304.
16. Kassabian VS. Sexual function in patients treated for benign prostatic hyperplasia. Lancet 2003;361:60-2.
17. Leliefeld HH, Stoevelaar HJ, McDonnell J. Sexual function before and after various treatments for symptomatic benign prostatic hyperplasia. Br J Urol Int 2002;89:208-13.
18. Gu RZ, Xia SJ. Surgical options for benign prostatic hyperplasia: impact on sexual function and risk factors. Natl J Androl 2011;17:837-41.
19. Arai Y, Aoki Y, Okubo K, et al. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol 2000;164:1206-11.
20. Ahyai SA, Gilling P, Kaplan SA, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 2010;58:384-97.
21. Cornu JN, Ahyai S, Bachmann A, et al. A systematic review and meta-analysis of functional outcomes and complications following trans-urethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 2015;67:1066-96.
22. Thangasamy IA, Chalasani V, Bachmann A, et al. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: a systematic review with meta-analysis from 2002 to 2012. Eur Urol 2012;62:315-23.
23. Lourenco T, Pickard R, Vale L, et al. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. Br Med J 2008;337:a449.
24. Biester K, Skipka G, Jahn R, et al. Systematic review of surgical treatments for benign prostatic hyperplasia and presentation of an approach to investigate therapeutic equivalence (non-inferiority). Br J Urol Int 2012;109:722-30.
25. Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. Eur Urol 2009;56:798-809.
26. Zong HT, Peng XX, Yang CC, et al. The impact of transurethral procedures for benign prostate hyperplasia on male sexual function: a meta-analysis. J Androl 2012;33:427-34.
27. Frieben RW, Lin HC, Hinh PP, et al. The impact of minimally invasive surgeries for the treatment of symptomatic benign prostatic hyperplasia on male sexual function: a systematic review. Asian J Androl 2010;12:500-8.
28. Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-14.
29. Yin X, Xiao Y, Li F, et al. Prognostic role of neutrophil-to-lymphocyte ratio in prostate cancer: a systematic review and meta-analysis. Medicine 2016;95: 3.
30. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Br Med J 2011;343:d5928.
31. Dhalwani NN, Tata LJ, Coleman T, et al. Completeness of maternal smoking status recording during pregnancy in United Kingdom primary care data. PloS One 2013;8:e72218.
32. Chen P, Zhang W, Wang X, et al. Lycopene and risk of prostate cancer. Medicine 2015;94: 33.
33. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J 2003;327:557-60.
34. van Valkenhoef G, Lu G, de Brock B, et al. Automating network meta-analysis. Res Synth Meth 2012;3:285-99.
35. Briganti A, Naspro R, Gallina A, et al. Impact on sexual function of holmium laser enucleation versus transurethral resection of the prostate: results of a prospective, 2-center, randomized trial. J Urol 2006;175: 1817-21.
36. Chen YB, Chen Q, Wang Z, et al. A prospective, randomized clinical trial comparing plasmakinetic resection of the prostate with holmium laser enucleation of the prostate based on a 2-year followup. J Urol 2013;189:217-22.
37. Chen Q, Zhang L, Fan QL, et al. Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. Br J Urol Int 2010;106: 1339-43.
38. Elmansy HM, Elzayat E, Elhilali MM. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial. J Urol 2010;184:2023-8.
39. Horasanli K, Silay MS, Altay B, et al. Photoselective potassium titanyl phosphate (KTP) laser vaporization versus transurethral resection of the prostate for prostates larger than 70mL: a short-term prospective randomized trial. Urology 2008;71:247-51.
40. Kumar A, Vasudeva P, Kumar N, et al. A prospective randomized comparative study of monopolar and bipolar transurethral resection of the prostate and photoselective vaporization of the prostate in patients who present with benign prostatic obstruction:a single center experience. J Endourol 2013;27:1245-53.
41. Mamoulakis C, Skolarikos A, Schulze M, et al. Bipolar vs monopolar transurethral resection of the prostate: evaluation of the impact on overall sexual function in an international randomized controlled trial setting. Br J Urol Int 2013;112:109-20.
42. Montorsi F, Naspro R, Salonia A, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2004;172(5 Pt 1):1926-9.
43. Naspro R, Suardi N, Salonia A, et al. Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70g: 24-month follow-up. Eur Urol 2006;50:563-8.
44. Rao JM, Yang JR, Ren YX, et al. Plasmakinetic enucleation of the prostate versus transvesical open prostatectomy for benign prostatic hyperplasia >80mL: 12-month follow-up results of a randomized clinical trial. Urology 2013;82:176-81.
45. Xia SJ, Zhuo J, Sun XW, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol 2008;53:382-9.
46. Xie JB, Tan YA, Wang FL, et al. Extraperitoneal laparoscopic adenomectomy (Madigan) versus bipolar transurethral resection of the prostate for benign prostatic hyperplasia greater than 80 ml: complications and functional outcomes after 3-year follow-up. J Endourol 2014;28:353-9.
47. Zhao Z, Zeng G, Zhong W, et al. A prospective, randomised trial comparing plasmakinetic enucleation to standard transurethral resection of the prostate for symptomatic benign prostatic hyperplasia: three-year follow-up results. Eur Urol 2010;58:752-8.
48. Zhu L, Chen S, Yang S, et al. Electrosurgical enucleation versus bipolar transurethral resection for prostates larger than 70 ml: a prospective, randomized trial with 5-year followup. J Urol 2013;189:1427-31.
49. Wang Y, Shao J, Lu Y, et al. Impact of 120-W 2-mum continuous wave laser vapoenucleation of the prostate on sexual function. Lasers Med Sci 2014;29:689-93.
50. Sinanoglu O, Ekici S, Tatar MN, et al. Postoperative outcomes of plasmakinetic transurethral resection of the prostate compared to monopolar transurethral resection of the prostate in patients with comorbidities. Urology 2012;80:402-6.
51. Bachmann A, Tubaro A, Barber N, et al. A European multicenter randomized noninferiority trial comparing 180W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol 2015;193:570-8.
52. Coskuner ER, Ozkan TA, Koprulu S, et al. The role of the bipolar plasmakinetic TURP over 100g prostate in the elderly patients. Int Urol Nephrol 2014;46:2071-7.
53. Taylor JM, Desouza R, Wang R. Common approach to managing lower urinary tract symptoms and erectile dysfunction. Asian J Androl 2008;10:45-53.
54. Gacci M, Eardley I, Giuliano F, et al. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2011;60:809-25.
55. Andersson KE, de Groat WC, McVary KT, et al. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol Urodyn 2011;30:292-301.
56. Kwon JS, Lee JW, Lee SW, et al. Comparison of effectiveness of monopolar and bipolar transurethral resection of the prostate and open prostatectomy in large benign prostatic hyperplasia. Korean J Urol 2011;52:269-73.
57. Muntener M, Aellig S, Kuettel R, et al. Sexual function after transurethral resection of the prostate (TURP): results of an independent prospective multicentre assessment of outcome. Eur Urol 2007;52:510-5.
58. Gacci M, Bartoletti R, Figlioli S, et al. Urinary symptoms, quality of life and sexual function in patients with benign prostatic hypertrophy before and after prostatectomy: a prospective study. Br J Urol Int 2003;91: 196-200.
59. Paick JS, Um JM, Kim SW, et al. Influence of high-power potassium-titanyl-phosphate photoselective vaporization of the prostate on erectile function: a short-term follow-up study. J Sex Med 2007;4:1701-7.
60. Bruyere F. The relationship between photoselective vaporization of the prostate and sexual function. Curr Urol Rep 2011;12:261-4.
61. Bruyere F, Puichaud A, Pereira H, et al. Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 2010;58: 207-11.
62. Kuntz RM, Ahyai S, Lehrich K, et al. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004;172:1012-6.
63. Meng F, Gao B, Fu Q, et al. Change of sexual function in patients before and after Ho:YAG laser enucleation of the prostate. J Androl 2007;28: 259-61.
64. Berardinelli F, Hinh P, Wang R. Minimally invasive surgery in the management of benign prostatic hyperplasia. Italian J Urol Nephrol 2009;61:269-89.
65. Dolowy L, Krajewski W, Dembowski J, et al. The role of lasers in modern urology. Central Eur J Urol 2015;68:175-82.
66. Kaiho Y, Nakagawa H, Saito H, et al. Nerves at the ventral prostatic capsule contribute to erectile function: initial electrophysiological assessment in humans. Eur Urol 2009;55:148-54.
67. Tscholl R, Largo M, Poppinghaus E, et al. Incidence of erectile impotence secondary to transurethral resection of benign prostatic hyperplasia, assessed by preoperative and postoperative Snap Gauge tests. J Urol 1995;153:1491-3.
68. Wasson JH, Reda DJ, Bruskewitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995;332:75-9.
69. Althof SE, Buvat J, Gutkin SW, et al. Sexual satisfaction in men with erectile dysfunction: correlates and potential predictors. J Sex Med 2010;7(1 pt 1):203-15.